RxDoctor Payments Data

Talea Foster

Nurse Practitioner · Columbus, OHNPI 1932562279

Payments from drug & device makers

$8,275in general payments, 2019–2025

Across 460 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$1K
  • Johnson & Johnson$1K
  • AbbVie$948
  • Alkermes, Inc.$905
  • Otsuka America Pharmaceutical, Inc.$893
  • Axsome Therapeutics, Inc.$735
  • plus $3K from 12 others

What the payments were for

  • Food & beverage$7,90095%
  • Education$3745%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,275 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate14$101,672
Austedo XrDeutetrabenazine17$100,635
Invega SustennaPaliperidone Palmitate35$92,106
IngrezzaValbenazine Tosylate11$85,402
CaplytaLumateperone Tosylate13$20,585
LybalviOlanzapine/Samidorphan Malate11$16,317
Paliperidone ErPaliperidone12$5,513
Aripiprazole67$5,327
Lurasidone Hcl15$1,786
Haloperidol47$1,458
Clozapine24$977
Duloxetine Hcl56$916
Benztropine Mesylate74$903
Olanzapine70$897
Ziprasidone Hcl16$783

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$1,076$193,77849 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$1,125$100,63517 claims
Neurocrine Biosciences, Inc.Ingrezza$730$85,40211 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$716$20,58513 claims
Alkermes, Inc.Lybalvi$905$16,31711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →